Article info
PDFEditorial
Matrix metalloproteinase-2: an emerging biomarker for reperfusion injury following percutaneous coronary intervention
- Correspondence to Dr Richard Schulz, Cardiovascular Research Centre, 4-62 HMRC, University of Alberta, Edmonton, AB T6G 2S2 Canada; richard.schulz{at}ualberta.ca
Citation
Matrix metalloproteinase-2: an emerging biomarker for reperfusion injury following percutaneous coronary intervention
Publication history
- First published September 13, 2011.
Online issue publication
October 25, 2017
Article Versions
- Previous version (30 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.